Spots Global Cancer Trial Database for remission
Every month we try and update this database with for remission cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors | NCT04916249 | Cancer Remission | Tibetree Pain R... Placebo | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer | NCT02756780 | Cancer | Tenovus Cancer ... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML) | NCT00398983 | Acute Myelogeno... | Decitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Reconstitution of CD4+CD25highCD127low/-Tcell | NCT03736044 | Rheumatoid Arth... | TNF-blockers su... | 18 Years - | University Hospital of Ferrara | |
| Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors | NCT04469530 | Solid Tumor | Sirolimus Cyclophosphamid... Etoposide Celecoxib | 1 Year - 30 Years | Emory University | |
| Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer | NCT02756780 | Cancer | Tenovus Cancer ... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129) | NCT00887068 | Leukemia AML MDS | Azacitidine | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer | NCT02007005 | Superficial Bla... | abnobaVISCUM Fr... | 18 Years - 80 Years | Abnoba Gmbh | |
| Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment | NCT05433077 | Non-Metastatic ... Remission Quality of Life | 18 Years - 75 Years | Centre Jean Perrin | ||
| Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment | NCT05433077 | Non-Metastatic ... Remission Quality of Life | 18 Years - 75 Years | Centre Jean Perrin | ||
| Phase IB/II of CPX-351 for Relapse Prevention in AML | NCT04990102 | Acute Myeloid L... | CPX-351 | 18 Years - | Georgetown University | |
| Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection | NCT05358158 | Lung Neoplasms Lung Surgery Enhanced Recove... Fast-track Surg... Pain Opioid Use Remission | Intraoperative ... Intraoperative ... Standard chest ... | 18 Years - | Rigshospitalet, Denmark | |
| Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer | NCT01322802 | Stage III Ovari... Stage III Ovari... Stage IV Ovaria... Stage IV Ovaria... | pUMVC3-hIGFBP-2... laboratory biom... | 18 Years - | University of Washington | |
| Maintenance Therapy in Acute Myeloid Leukemia (AML) Patients | NCT00957385 | Acute Myeloid L... | Revlimid | 18 Years - | University Health Network, Toronto | |
| Etanercept to Treat Wegener's Granulomatosis | NCT00001901 | Vasculitis Wegener's Granu... | Etanercept | - | National Institutes of Health Clinical Center (CC) | |
| Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML) | NCT00398983 | Acute Myelogeno... | Decitabine | 18 Years - | M.D. Anderson Cancer Center | |
| Reconstitution of CD4+CD25highCD127low/-Tcell | NCT03736044 | Rheumatoid Arth... | TNF-blockers su... | 18 Years - | University Hospital of Ferrara | |
| MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | NCT05735717 | Hematologic Mal... Acute Leukemia Remission Acute Myeloid L... Acute Lymphobla... AML TP53 Intrachromosoma... Cytogenetic Abn... CNS Leukemia Minimal Residua... Myelodysplasia Juvenile Myelom... Somatic Mutatio... PTPN11 Gene Mut... N-RAS Gene Ampl... Neurofibromatos... NF1 Mutation CBL Gene Mutati... Monosomy 7 Chromosome Abno... Fetal Hemoglobi... | Fludarabine Busulfan Melphalan Rituximab Levetiracetam | - 60 Years | Masonic Cancer Center, University of Minnesota | |
| Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer | NCT02007005 | Superficial Bla... | abnobaVISCUM Fr... | 18 Years - 80 Years | Abnoba Gmbh | |
| Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129) | NCT00887068 | Leukemia AML MDS | Azacitidine | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors | NCT04916249 | Cancer Remission | Tibetree Pain R... Placebo | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Etanercept to Treat Wegener's Granulomatosis | NCT00001901 | Vasculitis Wegener's Granu... | Etanercept | - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
